Scribe Therapeutics, Inc. ($SCTX)
Filing Information
| Accession Number | 0000902664-26-003270 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 29, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
2,391,238
Total Value
$36,259,761.25
P&L
+21.1% (+$7,643,368.43)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock, par value $0.0001 per share | โ | Jul 24, 2026 | Purchase | 2,333,333 | $15.00 | $34,999,995.00 | 3,030,983 | Indirect | See footnotes | View Details | |
Director | Common Stock, par value $0.0001 per share | โ | Jul 24, 2026 | Purchase | 50,000 | $22.31 | $1,115,500.00 | 3,080,983 | Indirect | See footnotes | View Details | |
Director | Common Stock, par value $0.0001 per share | โ | Jul 28, 2026 | Purchase | 7,905 | $18.25 | $144,266.25 | 3,088,888 | Indirect | See footnotes | View Details |